MSTN and Atrophy: For example, situations where atrophy is a prevalent symptom may display higher (Barreiro & Jaitovich, 2018; Man et al., 2010; Plant et al., 2010), lower (Loumaye et al., 2015) or comparable expression of myostatin (Brandt et al., 2012) in circulation.